Clinical trial
Hydrops: Diagnosing & Redefining Outcomes With Precision Study
NCT03412760 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Hydrops: Diagnosing & Redefining Outcomes With Precision Study
- Lead sponsor
- University of California, San Francisco
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- October 11, 2018
- Completion date
- February 28, 2027
- Enrollment
- 500 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
birth defect, fetal anomaly, hydrops fetalis